参考文献
1.Li H, Simpson ER, Liu JP. Oestrogen, telomerase, ovarian ageing and cancer. Clin Exp Pharmacol Physiol, 2010, 37: 78-82.
2.Gomez DE, Armando RG, Farina HG, et al. Telomere structure and telomerase in health and disease. Int J Oncol, 2012, 41: 1561-1569.
3.Chiodi I, Mondello C. Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front Oncol, 2012, 2: 33.
4.Kalmbach KH, Antunes DM, Kohlrausch F, et al. Telomeres and Female Reproductive Aging. Semin Reprod Med, 2015, 33 (6): 389-395.
5.Butts S, Riethman H, Ratcliffe S, et al. Correlation of telomere length and telomerase activity with occult ovarian insufficiency. J Clin Endocrinol Metab, 2009, 94: 4835-4843.
6.Cheng EH, Chen SU, Lee TH, et al. Evaluation of telomere length in cumulus cells as a potential biomarker of oocyte and embryo quality. Hum Reprod, 2013, 28: 929-936.
7.Keefe DL, Marquard K, Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gynecol, 2006, 18: 280-285.
8.Chronowska E. Regulation of telomerase activity in ovarian granulosa cells. Indian J Exp Biol, 2012,50: 595-601.
9.Farsetti A, Grasselli A, Bacchetti S, et al. The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling. J Appl Physiol, 2009, 106: 333-337.
10.Bayne S, Li H, Jones ME, et al. Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo. Protein Cell, 2011, 2: 333-346.
11.Qin CR, Chen SL, Yao JL, et al. Identification of novel missense mutations of the TGFBR3 gene in Chinese women with premature ovarian failure. Reprod Biomed Online, 2011, 23: 697-703.
12.Voorhuis M, Broekmans FJ, Fauser BC, et al. Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab, 2011, 96: 473-479.
13.Reddy P, Zheng W, Liu K. Mechanisms maintaining the dormancy and survival of mammalian primordial follicles. Trends Endocrinol Metab, 2010, 21: 96-103.
14.Stensen MH, Tanbo T, Storeng R, et al. Advanced glycation end products and their receptor contribute to ovarian ageing. Hum Reprod, 2014, 29 (1): 125-134.
15.Bierhaus A, Hofmarm MA, Ziegler R, et al. AGE and their interaction with AGE-receptorsin vascular disease and diabetes mellitus. Cardiovasc Res, 1998, 37 (3): 586-600.
16.Schmidt AM, Yan SD, Yan SF, et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Clin Invest, 2001, 108 (7): 949-955.
17.Tatone C, Amicarelli F, Carbone MC, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update, 2008, 14 (2): 131-142.
18.Wojsiat J, Korczyński J, Borowiecka M, et al. The role of oxidative stress in female infertility and in vitro fertilization. Postepy Hig Med Dosw (Online), 2017, 71 (0): 359-366.
19.Diamanti-Kandarakis E, Piperi C, Kalofoutis A, et al. Increased levels of serum advanced glycation endproducts in women with polycystic ovary syndrome. Clin Endocrinol, 2005, 62 (1): 37-43.
20.Irani M, Minkoff H, Seifer D, et al. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. Clin Endocrinol Metab, 2014, 99 (5): 886-890.
21.Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod, 2014,29 (1): 135-145.
22.Gonzalez Freire M, de Cabo R, Bernier M, et al. Reconsidering the Role of Mitochondria in Aging. J Gerontol A Biol Sci Med Sci, 2015, 70 (11): 1334-1342.
23.Tatone C, Carbone MC, Falone S, et al. Age dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol Hum Reprod,2006, 12 (11): 655-660.
24.Simsek Duran F, Li F, Ford W, et al. Age associated metabolic and morphologic changes in mitochondria of individual mouse and hamster oocytes. PLo S One, 2013, 8 (5): e64955.
25.Muller Hocker J, Schafer S, Weis S, et al. Morphological cyto-chemical and molecular genetic analyses of mitochondria in isolated human oocytes in the reproductive age. Mol Hum Reprod, 1996, 2 (12):951-958.
26.Seifer DB, De Jesus V, Hubbard K. Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in invitro fertilization. Fertil Steril, 2002, 78 (5): 1046-1048.
27.Barritt JA, Brenner CA, Cohen J, et al. Mitochondrial DNA rearrangements in human oocytes and embryos. Mol Hum Reprod, 1999, 5 (10): 927-933.
28.Wang J, Lu YY. Mitochondrial DNA 4977 bp deletion correlated with reactive oxygen species production and manganese superoxidedismutase expression in gastric tumor cells. Chin Med J (En-gl), 2009, 122 (4):431-436.
29.Chen X, Prosser R, Simonetti S, et al. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet, 1995, 57 (2): 239-247.
30.Kitagawa T, Suganuma N, Nawa A, et al. Rapid accumulation of deleted mitochondrial deoxyribonucleic acid in postmenopausal ovaries. Biol Reprod, 1993, 49 (4): 730-736.
31.Wilding M, Dale B, Marino M, et al. Mitochondrial aggregation patterns and activity in human oocytes and preimplantation embryos. Hum Reprod, 2001, 16 (5): 909-917.
32.Okado Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J Biol Chem, 2001, 276 (42): 38388-38393.
33.Ito M, Muraki M, Takahashi Y, et al. Glutathione S transferase theta 1 expressed in granulosa cells as a biomarker for oocyte quality in age related infertility. Fertil Steril, 2008, 90 (4): 1026-1035.
34.Zhang X, Wu XQ, Lu S, et al. Deficit of mitochondria derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res, 2006, 16 (10): 841-850.
35.Axelrod J, Reisine TD. Stress hormones: their interaction and regulation. Science, 1984, 224 (4648):452-459.
36.May-Panloup P, Boucret L, Chao de la Barca JM, et al. Ovarian ageing: the role of mitochondria in oocytes and follicles. Hum Reprod Update, 2016, 22 (6): 725-743.
37.Hall JE, Lavoie HB, Marsh EE, et al. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab, 2000, 85: 1794-1800.
38.Berga SL, Marcus MD, Loucks TL, et al. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril, 2003, 80 (4):976-981.
39.Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med, 1998, 129 (3): 229-240.
40.Pal L, Bevilacqua K, Santoro NF. Chronic psychosocial stressors are detrimental to ovarian reserve: a study of infertile women. J Psychosom Obstet Gynaecol, 2010, 31 (3): 130-139.
41.Li XF, Knox AM, O′Byrne KT. Corticotrophin-releasing factor and stress-induced inhibition of the gonadotrophin-releasing hormone pulse generator in the female. Brain Res, 2010, 1364: 153-163.
42.Calogero AE, Burrello N, Bosboom AM, et al. Glucocorticoids inhibit gonadotropin-releasing hormone by acting directly at the hypothalamic level. J Endocrinol Invest, 1999, 22 (9): 666-670.
43.Ferris RA, Mc Cue PM. The effects of dexamethasone and prednisolone on pituitary and ovarian function in the mare. Equine Vet J, 2010, 42 (5): 438-443.
44.Sasson R, Amsterdam A. Stimulation of apoptosis in human granulosa cells from in vitro fertilization patients and its prevention by dexamethasone: involvement of cell contact and bcl-2 expression. J Clin Endocrinol Metab, 2002, 87 (7): 3441-3451.
45.Gao HB, Tong MH, Hu YQ, et al. Glucocorticoid induces apoptosis in rat Leydig cells. Endocrinol, 2002,143 (1): 130-138.
46.Ruder EH, Hartman TJ, Blumberg J, et al. Oxidative stress and antioxidants: exposure and impact of female fertility. Hum Reprod Update, 2008, 14 (4): 345-357.
47.Zhang JM, Wang HC, Wang HX, et al. Oxidative stress and activities of caspase-8,-9, and -3 are involved in cryopreservation-induced apoptosis in granulosa cells. Eur J Obstet Gynecol Reprod Biol, 2013, 166 (1):52-55.